⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10964083 | 0.78 | — | — | |
| SCHEMBL2513261 | 0.76 | — | — | |
| SCHEMBL4140551 | 0.74 | — | — | |
| SCHEMBL28050729 | 0.71 | — | — | |
| SCHEMBL45479 | 0.70 | — | — | |
| SCHEMBL10520289 | 0.68 | — | — | |
| SCHEMBL84939 | 0.68 | — | — | |
| SCHEMBL6461529 | 0.68 | — | — | |
| Hydrochloric Acid SCHEMBL5169339 | 0.67 | — | — | |
| Hydrochloric Acid SCHEMBL1269497 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4358521-B2 | — | — | 2009-11-04 | — | — | JP | claimed |
| EP-1572067-A4 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | SIRNA THERAPEUTICS INC (US) | 2009-05-13 | — | — | EP | claimed |
| EP-1404349-B1 | FAT-BINDING POLYMERS | GENZYME CORP (US) | 2008-10-22 | — | — | EP | claimed |
| US-20060127353-A1 | Fat-binding polymers | GENZYME CORPORATION (US) | 2006-06-15 | — | — | US | claimed |
| US-7049345-B2 | Fat-binding polymers | GENZYME CORPORATION (US) | 2006-05-23 | — | — | US | claimed |
| EP-1572067-A2 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | Sirna Therapeutics, Inc. (US) | 2005-09-14 | — | — | EP | claimed |
| JP-2005505504-A | — | — | 2005-02-24 | — | — | JP | claimed |
| EP-1404349-A1 | FAT-BINDING POLYMERS | GENZYME CORPORATION (US) | 2004-04-07 | — | — | EP | claimed |
| US-20030104985-A1 | Conjugates and compositions for cellular delivery | BANK OF AMERICA, N.A. | 2003-06-05 | — | — | US | claimed |
| US-20030039626-A1 | Fat-binding polymers | GELTEX PHARMACEUTICALS, INC. | 2003-02-27 | — | — | US | claimed |
| WO-2003002130-A1 | FAT-BINDING POLYMERS | GENZYME CORPORATION (US) | 2003-01-09 | — | — | WO | claimed |
| WO-2002094185-A2 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | SIRNA THERAPEUTICS, INC. (US) | 2002-11-28 | — | — | WO | claimed |
| EP-3231445-A1 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | Sirna Therapeutics, Inc. (US) | 2017-10-18 | — | — | EP | disclosed |
| EP-3222294-A1 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | Sirna Therapeutics, Inc. (US) | 2017-09-27 | — | — | EP | disclosed |
| US-8461313-B2 | Conjugates and compositions for cellular delivery | SIRNA THERAPEUTICS, INC. (US) | 2013-06-11 | — | — | US | disclosed |
| US-20120202983-A1 | Conjugates and Compositions for Cellular Delivery | SIRNA THERAPEUTICS, INC. (US) | 2012-08-09 | — | — | US | disclosed |
| US-20030039626-A1 | Fat-binding polymers | GELTEX PHARMACEUTICALS, INC. | 2003-02-27 | — | — | US | disclosed |
| WO-2003002130-A1 | FAT-BINDING POLYMERS | GENZYME CORPORATION (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2003002571-A1 | ARYL BORONATE FUNCTIONALIZED POLYMERS FOR TREATING OBESITY | GENZYME CORPORATION (US) | 2003-01-09 | — | — | WO | disclosed |
| WO-2002094185-A2 | CONJUGATES AND COMPOSITIONS FOR CELLULAR DELIVERY | SIRNA THERAPEUTICS, INC. (US) | 2002-11-28 | — | — | WO | disclosed |